Here, we used a genome-wide CRISPR-Cas9 screen to identify targets whose depletion, together with PI3K inhibition by alpelisib, blocked proliferation of an EBV-associated gastric carcinoma model with hyperactive PI3K/mTOR signaling. This evidence concerns the gene MTOR and gastric carcinoma.